Premium

Distribution of the total global pharmaceutical market sales from 2014 to 2016, by submarket*

Exclusive Premium statistic

Get a Premium Account for unrestrained access.
Benefits of our Premium membership:

  • Access to all Premium statistics
  • Download as XLS, PNG and PDF
  • Detailed source and background information
Premium Account
$49 per month*
(billed annually)
*Single license
Loading statistic...
United StatesEuropeOther established marketsEmerging markets
-----
-----
-----
© Statista 2017

Show further information

Show sources information

AdvertisementTableau Software
 
About This Statistic

This statistic shows the distribution of the total global pharmaceutical market sales from 2014 to 3rd quarter of 2016, by submarket. In 2015, the U.S. pharmaceutical market generated some 46 percent of total global market sales.


Global pharmaceutical market

In 2006, the United States pharmaceutical market accounted for half of the world’s market, with other established markets only accounting for about 37 percent. More recently, the gap between the American market and other markets has shrunk. In 2015, the U.S. market accounted for 46 percent, emerging markets accounted for 20 percent, and Europe totaled 21 percent of the global pharmaceutical market.

Revenue generated by the pharmaceutical market has continued to rise in North America, generating almost 417 billion euros in 2015. The Asian, African, and Australasian market has experienced even larger growth, from 172 billion euros in 2010 to nearly 280 billion euros in 2016.

In the United States, the pharmaceutical market makes up a small part of overall healthcare spending. Growth in drug expenditures in the United States has also slowed likely due to increased costs for consumers, new generic medication, conversion to over the counter drugs, and safety concerns. A large portion of pharmaceutical expenditure is dedicated to oncologics, respiratory agents, lipid regulators, antidiabetics, and antipsychotics. The world’s pharmaceutical market reached some 1.07 trillion U.S. dollars of revenue in 2015.

Show more
Special Functions
Download as ...
Graphic (PNG)
Excel (XLS)
PowerPoint (PPT)
PDF
Options
Settings
Print
Research Alerts
Download started
Please be patient - this may take a moment

Statista Accounts: Access All Statistics. Starting from $588 / Year

Statistics on "Global pharmaceutical industry"

  • Overview
The most important statistics
  • Companies and products
The most important statistics
  • Top companies by revenue
  • R&D, patents, new entities
  • Outlook
The most important statistics

Related Studies: Available to Download in PDF or PPTX Format

U.S. pharmaceutical industry

All Information
in one Presentation

U.S. pharmaceutical industry

Everything On "U.S. pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers

Statista for Your Company: The Research and Analysis Tool

  • Product Film
  • Statistics
  • Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics.
93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Further Content: Statistics, Studies, and Topic Pages

Our Business Solutions: Save Time and Money

only

$588*

per year
Your advantages
  • Full access to all our statistics
  • Download as XLS, PDF & PNG
  • Relevant data: complete source information
All functions of our platform illustrated face-to-face
  • Learn how Statista supports your company
  • Extensive tour across the whole portal
  • Personal guidance by our support team
The knowledge database for your company
  • All functions of the Premium Account
  • Access to dossiers, forecasts and studies
  • Access to our international database
  • Publishing rights and other exclusive functions